Short seller Kerrisdale targets Woodford-backed Prothena

LONDON (Reuters) - Hedge fund Kerrisdale Capital has taken a short position in drugmaker Prothena, a company backed by UK investor Neil Woodford, calling it "the next big biotech blowup".